The US Food and Drug Administration's (USFDA) clearance to Sun Pharma’s manufacturing site at Halol has come as a big relief for the Indian pharmaceutical industry. After almost three years and two site inspections by USFDA investigators, there was relief and joy. One of the messages exchanged among executives of drug companies said, "It is not about Sun Pharma,
Read the full article now
Become a member
Insight-rich storytelling you won't find elsewhere by the finest team of business writers
Great conversations among an elite community of opinion leaders
A great reading experience across all your devices
Exclusive access to members-only events
Indian pharma has done. In the future it will have to take up much more complex manufacturing in biosimilars and innovative drugs. The world will source from India only when it knows that the medicine is what the doctor ordered. And to get there, Indian companies will have to ensure 24x7 readiness for a surprise visit by the USFDA investigator.